SCHEMBL23728834

SCHEMBL23728834

C=CCOCCOCCOCCOCCOCCC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.40
ALDH1A1 P00352 3/20 0.40
TP53 P04637 2/20 0.40
HIF1A Q16665 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPT P10636 2/20 0.39
ABCC4 O15439 1/20 0.39
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
POLB P06746 1/20 0.36
BLM P54132 2/20 0.34
PMP22 Q01453 1/20 0.34
LMNA P02545 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
SUCNR1 Q9BXA5 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12092189 1.00 TSHR (0.40) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL222657 0.96
Bicarbonate SCHEMBL28339996 0.86 ALDH1A1 (0.46) TSHRALDH1A1TP53HIF1AHSD17B10
Bicarbonate SCHEMBL347346 0.86 ALDH1A1 (0.46) TSHRALDH1A1TP53HIF1AHSD17B10
Bicarbonate SCHEMBL270124 0.86 ALDH1A1 (0.46) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL12092182 0.84 TSHR (0.47) TSHRALDH1A1TP53HIF1AHSD17B10
SCHEMBL12092216 0.84 TSHR (0.47) TSHRALDH1A1TP53HIF1AHSD17B10
Bicarbonate SCHEMBL10762215 0.84 POLB (0.43) TSHRALDH1A1TP53HIF1AHSD17B10
Bicarbonate SCHEMBL932354 0.84 POLB (0.43) TSHRALDH1A1TP53HIF1AHSD17B10
Succinic Acid SCHEMBL28486194 0.83 ABCC4 (0.36) TSHRALDH1A1TP53HIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100404-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2022-12-14 EP disclosed
WO-2021158707-A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE Design Therapeutics, Inc. (US) 2021-08-12 WO disclosed